跳至主要内容
临床试验/ITMCTR1900002263
ITMCTR1900002263尚未招募3 期

The multicenter randomized controlled study for Qihuang yishen granule improve proteinuria of diabetic kidney disease

Wangjing Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
30 至 75(—)
性别
All

入选标准

  • ? meet the Western diagnostic criteria of Diabetic kidney disease and diagnostic criteria for TCM syndromes;
  • ? age 30 to 75 years (including 30 and 75 years);
  • ? 24h urine protein quantification between 0.5 ~ 3.5g, eGFR30 ~ 90ml/min;
  • ? after antihypertensive treatment, the blood pressure is controlled at =140/90mmHg;
  • ? the blood sugar is stable, and the glycated hemoglobin is below 8%;
  • ? signed informed consent, outpatient and inpatients who can be followed up for a long time.

排除标准

  • ? blood pressure <90/60mmHg;
  • ? patients with blood creatinine increased to 2 times in the past six months;
  • ? unilateral or bilateral renal artery stenosis;
  • ? other serious diabetic complications and severe macrovascular events in the past six months, such as cerebral hemorrhage, large-area cerebral infarction, acute myocardial infarction;
  • ? patients with various infectious diseases in the past 4 weeks;
  • ? combined with other serious diseases, such as blood system diseases, malignant tumors, etc.;
  • ? serious psychological or mental abnormalities;
  • ? pregnant or lactating women.
  • Note: Any item that meets the above conditions will not be included in this study.

研究者

发起方
Wangjing Hospital, China Academy of Chinese Medical Sciences

相似试验